Literature DB >> 9255876

Hepatitis A outbreak amongst intravenous amphetamine abusers in Finland.

T Leino1, P Leinikki, T Hyypiä, M Ristola, J Suni, J Sutinen, A Holopainen, O Haikala, M Valle, T Rostila.   

Abstract

This article describes a widespread outbreak of hepatitis A virus (HAV) infection amongst drug abusers in Finland. Although attempts to demonstrate the virus in amphetamines failed, the infection was assumed to be linked to intravenous use of the drug. The unusual mode of transmission prompted us to analyse possible atypical clinical features as well as the spread of the virus to the general population, nowadays practically without protective immunity. Serologically verified cases that occurred in Helsinki were interviewed, their hospital records were analysed and their contacts were serology tested. Amphetamine lots, as well as faecal samples from patients, were examined with RT-PCR. Detailed information was obtained from 238 subjects, among whom 131 admitted drug abuse and 67 cases were classified as secondary cases. Phylogenetic analysis of virus strains from HAV-infected cases suggested a common origin, and epidemiological observations linked it with particular lots of amphetamine. Three cases died, and 3 presented with severe clinical disease. Icterus was more common among i.v. drug abusers than others. Infection with hepatitis A virus was probably related to the faecal contamination of amphetamine associated with the transportation of the drugs in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255876     DOI: 10.3109/00365549709019029

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

Review 1.  Diagnosis of hepatitis a virus infection: a molecular approach.

Authors:  Omana V Nainan; Guoliang Xia; Gilberto Vaughan; Harold S Margolis
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Vulnerability to drug-related infections and co-infections among injecting drug users in Budapest, Hungary.

Authors:  V Anna Gyarmathy; Alan Neaigus; Eszter Ujhelyi
Journal:  Eur J Public Health       Date:  2009-02-17       Impact factor: 3.367

3.  Genetic analysis of hepatitis A virus strains that induced epidemics in Korea during 2007-2009.

Authors:  Hyeokjin Lee; Hyesook Jeong; Heasun Yun; Kisang Kim; Jong-Hyun Kim; Jai Myung Yang; Doo-Sung Cheon
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

4.  Comparative hepatitis A seroepidemiology in 10 European countries.

Authors:  S Kurkela; R Pebody; G Kafatos; N Andrews; C Barbara; B Bruzzone; D Butur; S Caplinskas; I Davidkin; A Hatzakis; W Hellenbrand; L M Hesketh; A Nardone; V Nemecek; A Pistol; Z Sobotová; R Vranckx; C G Anastassopoulou
Journal:  Epidemiol Infect       Date:  2012-01-25       Impact factor: 4.434

Review 5.  Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review.

Authors:  Kuan-Yin Lin; Guan-Jhou Chen; Yu-Lin Lee; Yi-Chia Huang; Aristine Cheng; Hsin-Yun Sun; Sui-Yuan Chang; Chun-Eng Liu; Chien-Ching Hung
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

Review 6.  Amphetamine, past and present--a pharmacological and clinical perspective.

Authors:  David J Heal; Sharon L Smith; Jane Gosden; David J Nutt
Journal:  J Psychopharmacol       Date:  2013-03-28       Impact factor: 4.153

Review 7.  Foodborne viruses.

Authors:  Marion Koopmans; Carl Henrik von Bonsdorff; Jan Vinjé; Dario de Medici; Steve Monroe
Journal:  FEMS Microbiol Rev       Date:  2002-06       Impact factor: 16.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.